A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)
Clinical trial NCT03539549 · COMPLETED
Trial details
- NCT number
- NCT03539549
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2019-02-27
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.